ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
08 août 2023 07h00 HE
|
ADC Therapeutics SA
2Q 2023 ZYNLONTA®1 net sales increased 11% year-over-year; Implemented new go-to-market strategy during the quarter to support growth Operating expenses decreased 20%2 year-over-year due to portfolio...
Overland ADCT BioPharma Announces NMPA Accepts Biologics License Application and Grants Priority Review for ZYNLONTA® for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
24 juil. 2023 07h21 HE
|
ADC Therapeutics SA
BOSTON and SHANGHAI, China and LAUSANNE, Switzerland, July 24, 2023 (GLOBE NEWSWIRE) -- Overland ADCT BioPharma, a joint venture of Overland Pharmaceuticals (CY) Inc. and ADC Therapeutics SA (NYSE:...
Global Multiple Myeloma Market Research Report 2023-2030: Top 10 Markets, Epidemiology, Marketed Products, Pipeline Drugs, Patient Journey, Competitive Landscape
12 juin 2023 07h08 HE
|
Research and Markets
Dublin, June 12, 2023 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis"...
Global Gastric Cancer Market Expected to Accumulate a Revenue of $10,737.00 Million by 2031, Growing at a Healthy CAGR of 17.9% [350-Pages] | Initiative by Research Dive
01 juin 2023 09h02 HE
|
Research Dive
New York, USA, June 01, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global gastric cancer market is anticipated to rise at a stable CAGR of 17.9%, thereby...
ADC Therapeutics to Participate in the Jefferies Healthcare Conference
01 juin 2023 07h15 HE
|
ADC Therapeutics SA
LAUSANNE, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the...
Tessa Therapeutics’ Autologous and Allogeneic Cell Therapy Data to be Featured at the 17th International Conference on Malignant Lymphoma, Lugano
30 mai 2023 06h12 HE
|
Tessa Therapeutics Ltd
SINGAPORE, May 30, 2023 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and...
Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline
12 avr. 2023 07h30 HE
|
Adaptive Biotechnologies
SEATTLE, April 12, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
Global BCL-2 (B-cell lymphoma 2) Inhibitors Market to Grow by $1.65 Billion During 2023-2027
15 mars 2023 08h13 HE
|
Research and Markets
Dublin, March 15, 2023 (GLOBE NEWSWIRE) -- The "Global BCL-2 (B-cell lymphoma 2) Inhibitors Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.The BCL-2 (B-cell Lymphoma...
Global Hemato Oncology Testing Market Report 2022 to 2027: Drug Diagnostics Co-Development Presents Opportunities
12 déc. 2022 08h14 HE
|
Research and Markets
Dublin, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The "Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma...
Global Leukapheresis Market Report 2022: Increased Demand for Leukopaks in Clinical Research Driving Growth
25 oct. 2022 06h28 HE
|
Research and Markets
Dublin, Oct. 25, 2022 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma),...